Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
about
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressantsTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to datePossible pathophysiology of ketamine-related cystitis and associated treatment strategiesGene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in miceA single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in ratsBDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers.Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTORKetamine as antidepressant? Current state and future perspectives.Ketamine as a fast acting antidepressant: current knowledge and open questions.Nerve hyperplasia: a unique feature of ketamine cystitis.BDNF-ERK1/2 signaling pathway in ketamine-associated lower urinary tract symptoms.AMPA receptor potentially participates in the mediation of the increased brain-derived neurotrophic factor following chronic ketamine use.Enhanced BDNF serum levels in patients with severe pathological gambling.
P2860
Q21129276-D96C2DFB-3643-4AB6-B8EC-60A9477B32B3Q27004490-CB671A12-EB48-471F-B899-1D4FECB01683Q27013111-4B771151-3AF6-4256-94AC-BBB496F3545CQ28478665-103D4142-14AC-42A9-BE49-02D4CE44358AQ35569752-2205DA58-4840-4864-A1FB-794DD8EB6A4DQ36377832-66DE7E4D-376E-4090-9EC5-DFBEACE1268DQ36956267-D245F5D9-27FA-41CD-823B-DEBE37CC2823Q37248524-FBC3D94C-83F0-4652-B143-104DD2A74D5CQ37559823-F940B9C4-397E-4C26-8132-6FADEC25F06AQ38098265-6FBACC52-A50F-461B-8134-9281A2F6E04FQ41874803-F26834EA-A75A-473A-8A91-92BBA319C075Q47432301-E9AA193D-A98D-4A31-8D6A-C3A038DA5E66Q48221352-B6E454F3-485B-4906-A51F-EB9175603920Q51848804-7DB96775-0148-4D08-9C6D-8C193CE398AC
P2860
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
@en
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
@nl
type
label
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
@en
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
@nl
prefLabel
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
@en
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
@nl
P2093
P2860
P1433
P1476
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor.
@en
P2093
Federico Tonioni
Francesca Gelfo
Francesco Angelucci
Giovanni Martinotti
Pietro Bria
Valerio Ricci
P2860
P2888
P304
P356
10.1007/S00213-010-2121-3
P577
2010-12-14T00:00:00Z